TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$96.43+2.52 (+2.68%)
Close on Nov 18, 2026Market cap $3.34BP/E 25.0Yield 0.00%
TransMedics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
TransMedics's revenue for the twelve months ending Jun 30, 2026 was $668.47M, up 25.8% year over year. For fiscal 2025 it was $605.49M, up 37.1% from the year before. The highest annual figure on record is $605.49M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $605.49M | +37.1% |
| FY2024 | Dec 31, 2024 | $441.54M | +82.7% |
| FY2023 | Dec 31, 2023 | $241.62M | +158.5% |
| FY2022 | Dec 31, 2022 | $93.46M | +208.8% |
| FY2021 | Dec 31, 2021 | $30.26M | +18.0% |
| FY2020 | Dec 31, 2020 | $25.64M | +8.6% |
| FY2019 | Dec 28, 2019 | $23.60M | +81.3% |
| FY2018 | Dec 29, 2018 | $13.02M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $189.95M | +20.7% |
| Q1 FY2026 | Mar 31, 2026 | $173.93M | +21.2% |
| Q4 FY2025 | Dec 31, 2025 | $160.76M | +32.2% |
| Q3 FY2025 | Sep 30, 2025 | $143.82M | +32.2% |
| Q2 FY2025 | Jun 30, 2025 | $157.37M | +37.7% |
| Q1 FY2025 | Mar 31, 2025 | $143.54M | +48.2% |
| Q4 FY2024 | Dec 31, 2024 | $121.62M | +49.8% |
| Q3 FY2024 | Sep 30, 2024 | $108.76M | +63.7% |
| Q2 FY2024 | Jun 30, 2024 | $114.31M | +117.9% |
| Q1 FY2024 | Mar 31, 2024 | $96.85M | +133.1% |
| Q4 FY2023 | Dec 31, 2023 | $81.17M | +158.7% |
| Q3 FY2023 | Sep 30, 2023 | $66.43M | +158.7% |
| Q2 FY2023 | Jun 30, 2023 | $52.47M | +155.7% |
| Q1 FY2023 | Mar 31, 2023 | $41.55M | +161.7% |
| Q4 FY2022 | Dec 31, 2022 | $31.38M | +224.5% |
| Q3 FY2022 | Sep 30, 2022 | $25.68M | +378.3% |
| Q2 FY2022 | Jun 30, 2022 | $20.52M | +151.1% |
| Q1 FY2022 | Mar 31, 2022 | $15.88M | +125.2% |
| Q4 FY2021 | Dec 31, 2021 | $9.67M | +26.8% |
| Q3 FY2021 | Sep 30, 2021 | $5.37M | -24.3% |
| Q2 FY2021 | Jun 30, 2021 | $8.17M | +141.0% |
| Q1 FY2021 | Mar 31, 2021 | $7.05M | -6.3% |
| Q4 FY2020 | Dec 31, 2020 | $7.63M | +25.9% |
| Q3 FY2020 | Sep 30, 2020 | $7.09M | -1.6% |
| Q2 FY2020 | Jun 30, 2020 | $3.39M | -40.2% |
| Q1 FY2020 | Mar 31, 2020 | $7.53M | +61.0% |
| Q4 FY2019 | Dec 28, 2019 | $6.06M | +70.9% |
| Q3 FY2019 | Sep 28, 2019 | $7.21M | +78.4% |
| Q2 FY2019 | Jun 29, 2019 | $5.67M | +94.4% |
| Q1 FY2019 | Mar 30, 2019 | $4.68M | +85.6% |
| Q4 FY2018 | Dec 29, 2018 | $3.54M | – |
| Q3 FY2018 | Sep 29, 2018 | $4.04M | – |
| Q2 FY2018 | Jun 30, 2018 | $2.92M | – |
| Q1 FY2018 | Mar 31, 2018 | $2.52M | – |
See a number that looks wrong?